Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Effective as of November 9, 2021, the following individual(s) were appointed to
the Board of Directors of the Registrant:
Name Age Position
Jim Morrison 62 Chairman of the Board of Directors
Dr. Babak "Bobby" Ghalili 56 Director
Jim Morrison was previously President of L'Oréal for 9 years, he acquired Redken
and Matrix and led a top-line growth average above 20%. As CEO, he headed the
first celebrity-driven video shopping app in partnership with SPRINT; Graham
Webb, one of the most successful startups in hair care; and Sexy Hair Concepts
for four years. He has served as President/CEO and a Director of Regen
Biowellness, Inc., (formerly Availa Bio, Inc.), since May 2020, a health and
wellness product provider.
Dr. Babak "Bobby" Ghalili, DMD, is one of the foremost periodontal and
reconstructive dental surgeons in the field, he is an Associate Professor of
Periodontal Surgery at New York University and the University of Medicine and
Dentistry of New Jersey. Dr. Ghalili is a graduate of Brandeis University, Tufts
University, and UMDMJ, and author of 21 patents (6 awarded patents and 15 patent
pending).
Effective as of November 9, 2021, the following has resigned as a Director of
the Registrant but shall remain as Vice President of Operations/Compliance
reporting directly to the Board of Directors.
Name Position
James W. Zimbler Vice-President/Director
The Director resigning has stated in his resignation letter that his resignation
as president does not in any way imply or infer that there is any dispute or
disagreement relating to the Company's operations, policies or practices. Mr.
Zimbler will remain as Vice President of Operations/Compliance and a Special
Advisor to the Board of Directors.
Each resigning Officer has been provided a copy of his disclosure, no less that
the day the Registrant is filing the disclosure with the Commission. Each
Officer will be given an opportunity to furnish the Registrant a letter or
response, that he agrees with the statements made by the Registrant in this
Section 5.02, and if not, stating the respects in which he does not agree.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits.
Exhibit No. Exhibit
Resignation Letter of James W. Zimbler as Vice-President and
17.1 Director, dated November 1, 2021
2© Edgar Online, source Glimpses
CANNAGIST